"10.1371_journal.pone.0047716","plos one","2012-11-09T00:00:00Z","Masahiro Omoto; Satoru Yoshida; Hideyuki Miyashita; Tetsuya Kawakita; Kenji Yoshida; Akiyoshi Kishino; Toru Kimura; Shinsuke Shibata; Kazuo Tsubota; Hideyuki Okano; Shigeto Shimmura","Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan; Genomic Science Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Tokyo, Japan; Department of Physiology, Keio University School of Medicine, Tokyo, Japan","Conceived and designed the experiments: MO S. Shimmura KT HO. Performed the experiments: MO SY KY HM. Analyzed the data: MO SY HO HM T. Kawakita. Contributed reagents/materials/analysis tools: KY AK T. Kimura S. Shibata. Wrote the paper: S. Shimmura MO SY HO.","The authors have read the journal's policy and have the following conflicts: MO, KT, HO and SS have applied for patent application on the use of Sema3A inhibitor for nerve regeneration [Application no. 2011-040128 (Japan)]. KY, AK, and TK are employees of Dainippon Sumitomo Pharma Co., Ltd. They have provided material for the study but were not involved in the study design or collection, analysis and interpretation of data. They were involved in the decision to submit the paper. These facts do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","11","Masahiro Omoto","MO",11,TRUE,2,4,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
